Transcription factors (TFs) usually function as cis-regulatory modules (CRMs) to activate enhancers or promoters and regulate target gene transcription. Cell typespecific ChIP-seq profiling of multiple TFs makes it feasible to infer functional CRMs for a particular cell type. Directly using ChIP-seq peaks may only recover CRMs partially since some weak binding events are likely missed by peak callers, resulting in an incomplete identification of co-binding events. We have developed a novel samplingbased approach, ChIP-GSM, for CRM inference and active regulatory element prediction. The approach uses a mixture model of Power-Law and Gamma distributions to model read counts in the foreground and background regions that enable the capture of more foreground regions regulated by CRMs with weak binding affinity. Specifically, ChIP-GSM samples read counts of multiple TFs iteratively for the joint effect of each potential TF combination; using inferred CRMs as novel features, ChIP-GSM employs logistic regression to accurately predict active regulatory elements. We first benchmarked ChIP-GSM on simulated ChIP-seq data and real data with known CRMs.
then applied ChIP-GSM to ChIP-seq data acquired from breast cancer MCF-7 cells and revealed that CRMs are functional distinctly at enhancer and promoter regions. To broaden the applicability of ChIP-GSM, we further deployed ChIP-GSM to infer CRMs from 9 different cell types and used CRMs as features to predict active enhancers or target genes; the performance of ChIP-GSM is significantly improved over that of using individual TF peaks. Finally, we performed functional enrichment analysis of the target genes of CRMs inferred from K562 cells and demonstrated that CRMs are likely to be active at different time points to mediate distinct cellular functions.
Introduction
ChIP-seq profiling provides a quantitative measurement of binding of a specific transcription factor (TF) to DNA regions or sites 1 . TFs often cooperate by forming cisregulatory modules (CRMs) to regulate target genes through activating enhancer or promoter regions 2 , where one or two TFs may serve as major regulators (or factors) and recruit other co-factors to perform context specific regulation 3 . Joint analysis of multiple TFs' ChIP-seq profiles has become a powerful tool to study the cell typespecific regulatory mechanism. Several CRM identification approaches have been proposed based on ChIP-seq data. For example, ChromHMM 4 infers chromatin states using ChIP-seq peak files of multiple histone markers. jMOSAiCS 5 infers the most reliable module at each genomic segment. SignalSpider 6 better utilizes 'weak' binding signals during module inference by modeling read coverage instead of the read count.
However, input data are not used in this method and the false positive rate in the results cannot be ignored, especially when weak peaks are included in the analysis. As shown in 7
, input data play a key role in differentiating weak peaks from background signals. To interpret the function of CRMs, functional studies like analyzing the function of individual TFs, target genes expression, or gene set functional enrichment are needed. Therefore, instead of working on broad genome regions, inferring CRMs at enhancer or promoter regions would better explain CRM functions because we can associate target genes with those regions based on existing biological knowledge.
It is also important to predict active regulatory regions based on CRMs since a regulatory region is usually activated by a CRM rather than a single TF [8] [9] [10] . A prediction method, EMERGE
11
, was proposed to predict active regulatory elements based on TF bindings. For a cell type, EMERGE merges all cell type-specific ChIP-seq datasets and uses a logistic regression framework 12 to predict genomic regulatory regions. If TF ChIP-seq datasets are used, it assigns a weight to each TF, labels presence or not of each region in all ChIP-seq datasets and uses a weighted sum of TF bindings at each region for active regulatory element prediction. As regulatory regions are activated by
CRMs rather than a single or all TFs, we expect that using CRMs to predict active regulatory elements should have a better prediction power than using a weighted sum of individual TFs.
We develop a Gibbs sampling-based approach, ChIP-GSM, for CRM inference and active regulatory region prediction from multiple ChIP-seq profiles. We assume that a foreground region (targeting by a specific TF's antibody during the 'ChIP' process) is more likely to be sequenced multiple times during the 'seq' step than any background regions (non-specific binding area). For each TF, we use a mixture model of Power-Law and Gamma distributions 13 to model read counts sequenced from foreground or background regions, respectively. ChIP-GSM assigns each region a weight (a probability) representing the probability that this current region will be sequenced. This weight is calculated based on the observed read count and Power-Law or Gamma distribution, depending on whether it is a foreground or background region. The sum of all weights equals to 1. Then, under a Gibbs sampling framework, we infer the most reliable CRM (a combination of TFs) at each foreground region by updating the weight of each TF iteratively with the sampling of CRMs. The sampling frequency of each CRM represents the posterior probability. For each CRM, the average sampling frequency at all regions denotes its relative importance in the cell, which can be used to prioritize
CRMs. Based on inferred CRMs, ChIP-GSM further uses a logistic regression approach 12 to predict whether cis-regulatory regions are active or not for a particular cell type.
To demonstrate the capability of ChIP-GSM on CRM inference, we applied ChIP-GSM to simulated ChIP-seq profiles and compared its performance with existing methods.
The superior performance on capturing more foreground regions of weak enrichment makes ChIP-GSM more feasible to use in real ChIP-seq data analysis, especially in large-scale studies with many TFs and diverse TF-DNA binding strengths. We then benchmarked ChIP-GSM and competing methods on a H1-hESC cell ChIP-seq data set, including two TFs and two histone markers and known association relationships. Our results show that ChIP-GSM captures more regions under regulation of high order TF combinations. As a real application, we used ChIP-GSM to infer CRMs from MCF-7 breast cancer cells. We found that CRMs acting at enhancer and promoter regions are quite different. We continued CRM inference on another 8 cell types. We aimed to examine whether TF combinations as CRMs have a stronger prediction power on active enhancers/genes than individual TFs, and whether this is true in different cell types. For each cell type, active/non-active enhancers or genes were selected from the FANTOM5 database based on their expression value. Using logistic regression, the prediction performance of using CRMs is significantly improved when compared with using binary TF peaks. Finally, we studied CRMs inferred from promoter regions of K562 cells, which have the best prediction performance on active regions. Based on TF similarity, we classified CRMs into several groups and found that each group regulates very distinct sets of target genes. Further validation using a time-course gene expression dataset shows that after a stimulus, each group of CRMs are active at a specific time points and involved in the regulation of a unique set of cellular processes.
Methods

Description of the ChIP-GSM approach
The workflow of ChIP-GSM is shown in Fig. 1 
where is the exponential decaying parameter; denotes region length; is the length of promoter. is specific for the -th TF and needs to be estimated from the location distribution of foreground regions. We assume a prior Gamma distribution (conjugate prior of exponential distribution 16 ) on with hyper-parameters a n d .
From Supplementary Table S12 , it can be found that the enrichment of real ChIP-seq data along the promoter region is well fitted using the proposed distance-based mixture model. In enhancer study, for both foreground and background regions, this effect is uniformly distributed at the whole enhancer region.
Given read counts candidate modules matrix B , observed read counts matrix and binding location matrix in order to estimate ,
(for promoter focused study only), and C at foreground regions, or at background regions, we define a posterior probability ( , , , | , , )
. and can be learned from the sample ChIP-seq profile of the tth TF by setting the minimum read count to a small number (e.g., 10 in our implementation). and can be learned from the ChIP-seq input profile prepared for the t-th TF. We assume an informative prior on with parameters and , and a non-informative prior on with parameters and . We convert the module identification problem to an optimization problem by maximizing the posterior probability ( , , , | , , , )
Considering that the total number of read tags in each ChIP-seq dataset is limited, read counts at different regions are not independent. In our proposed method, for the k-th region we calculate a weight based on the estimated read count 
Gibbs sampling process
I. Model initialization
For the t-th ChIP-seq profile, we first roughly estimate the total number of reads to be assigned to foreground (or background) regions. Initially, we assume that all regions are background regions (before a TF specific antibody is applied to the cell) and randomly Assuming that the total number of reads in the t-th TF ChIP-seq dataset is , the ratio between the total numbers of reads assigned to foreground regions ( , X t R ) and background regions ( , I t R ) can be calculated as follows:
(1 )
where
II. Sampling read counts
For foreground regions, given 
For background regions, in total , I t R reads should be assigned to individual regions according to their weights as defined in the following equation:
III. Sampling model parameters
There are two unknown model parameters as exponential distribution parameter and the noise variance . The conditional probability of can be calculated as follows:
As demonstrated in Supplementary Material S10, Eq. (7) is a Gamma distribution so we sample according to a Gamma distribution with parameters , , , ,
represents the overall fitting performance between the observed and estimated read counts. The conditional probability of is defined as follows:
where 
IV. Sampling CRMs
The sampling of CRM for each region can be achieved by calculating a discrete probability density distribution of all candidate CRMs. At the -th region, for each candidate CRM we calculate a conditional probability We collect probabilities for all candidate CRMs at each region and then randomly sample a CRM according to the discrete probability distribution. After repeating CRM sampling at all regions, we bring an updated matrix C back to Eq. (4) to 
Active regulatory region prediction
Given the inferred module results as Ĉ , we determine an optimal set of weights (β) for
CRMs so as to predict the activity of each regulatory region. term that includes the values of weights (β) in the minimization process: 
Results
Realistic simulation
We performed realistic simulation by simulating ChIP-seq read counts according to real
ChIP-seq data. The advantages of this approach are (1) in real data, each TF is unique in both ChIP-seq read count distribution and binding locations; (2) Table S1 ). Read count distributions of several TFs ChIP-seq profiles and the input profile are provided in Supplementary Fig. S1 . For each case, we generated 10 replicates by randomly Capability of the CRM inference is mainly reflected by the full recovery of all 'true' bindings at each region. A F-measure (F=2/(1/precision+1/recall)) is used to evaluate the performance of each method (Fig. 2) . As can be seen from Fig. 2 , ChIP-GSM provides improved performance over existing methods tested here. While for regions with at least one 'weak' binding event from any TF (read count < 50), ChIP-GSM provides a more significantly improved performance over competing methods.
Benchmarking ChIP-GSM on modules with known associations
We downloaded a ChIP-seq data set with four factors (H3K27me3, H3K4me3, EZH2, (Fig. 3(A) ).
ChIP-GSM has the largest proportion of foreground regions under the regulation of all four factors (the longest red bar as shown in Fig.3(B) ). The read count distributions at 
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Inferring cell type-specific CRMs from enhancer or promoter regions
We further examined the TF-association differences in CRMs inferred from enhancer and promoter regions. We checked all cell types with ChIP-seq data in ENCODE database and selected 9 cell types for which the number of TF ChIP-seq profiles was larger than 20 and cell type-specific enhancer regions were also available (Supplementary Tables S2 and S3 ). We downloaded MCF-7 ChIP-seq data of 69 TFs and also its cell type-specific enhancer regions from the ENCODE database. Promoter regions were extracted from the human RefSeq file using the UCSC genome browser (human reference genome hg19). Details for this procedure can be found in Supplementary Section S5. Using ChIP-GSM, we identified 52 CRMs including 34
TFs at enhancer regions, and 66 CRMs including 28 TFs at promoter regions.
Similarities of ChIP-GSM identified TFs or CRMs between enhancer and promoters studies were respectively shown in Fig.4A . TF similarity (2*overlap/(no. of enhancer study + no. of promoter study)) is 77%, while CRM similarity is only 54%. We further checked TF similarity vs. CRM similarity in the other cell types (Fig.4B ) and found that given a similar set of TFs at enhancer or promoter regions (average similarity 77%), the similarity of TF-associations (CRMs) is significant lower. In other words, CRMs are significantly different between enhancer and promoter regions, indicating their different functional categories in the whole genome. Therefore, for the same set of TFs, considering the specificity of CRMs at enhancer or promoter, it is necessary to infer CRMs respectively at these two different types of regions. 
Predicting active enhancers or promoters using inferred CRMs
We extended our CRM inference to another 8 cell types with at least 20 TFs in the ENCODE ChIP-seq database (Supplementary specificity, the average AUC for active enhancer prediction is 0.81 using CRMs as compared to 0.74 using TFs (Fig. 5(C) ). The overall AUC performance using CRMs inferred from ChIP-GSM is significantly better than using TFs (EMERGE). As shown in 
CRM function interpretation and target gene analysis
CRMs identified from promoter regions using ChIP-seq data of K562 cells have the best prediction performance on active promoters (green circle in Fig. 5(B) Table S6 , Supplementary Fig. S4 ). Compared with existing methods that can work on large-scale CRM inference using ChIP-seq data ( Supplementary Figs. S5~S7 ), modeling raw ChIP-seq read counts rather than significant peaks provides an opportunity to discover some less dominant but biologically important modules. We filtered the 68 CRMs using two conditions: (1) each CRM regulates at least 500 foreground regions; (2) the posterior probability of each CRM is larger than 0.4. After filtering, 30 CRMs that include 39 TFs (~80% of all investigated TFs) were selected. We clustered these 30 CRMs using hierarchical clustering based on TF similarity (Fig. 6(A) and Supplementary Fig. S4 ) and identified 8 groups. For each group, we examined the functions of the TFs and found a significant enrichment of similar functions (Supplementary Material S6) . We also checked coexpression between pairwise TFs in each group, since cooperative TFs are usually active simultaneously 22, 23 . We downloaded time-course gene expression data (GSE1036) 24 and calculated the Pearson correlation coefficient for pairwise TFs ( Supplementary Fig. S8 ). 6 out of 8 groups (75%) had significantly co-expressed TFs.
TF co-expression in Group 2 or Group 4 was less significant but the functions of TFs in each group were closely related. For example, CBX2, CBX8, RNF2, EZH2 and SUZ12
in Group 2 are all Polycomb-group proteins 25 .
4
We then analyzed the target genes of each CRM. Gene symbols can be found in Supplementary Table S7 . The similarity of downstream target genes for the identified CRMs is shown in Supplementary Fig. S9 . CRMs from the same group regulate distinct sets of target genes even though they share one or two common factors. Table S8 ). Functional genes of each significant CRM can be found in Supplementary Table S9 . Using k-means clustering, we identified 8 clusters with a unique gene expression pattern in each. We assessed the functional gene enrichment for each pair of CRM and gene cluster. Numbers of genes in each cluster can be found in Supplementary Table S10 . As shown in Fig. 6(C 
Discussion
Inferring CRMs among TFs is quite challenging because compared to histone modification signals, TF binding peaks are shorter, noisier, and more sensitive to the cell environment. We developed a probabilistic model, ChIP-GSM, for inferring cisregulatory modules and predicting active regulatory elements. ChIP-GSM better models ChIP-seq read counts of strong and weak binding events so that many CRMs and regulatory regions containing weak binding TFs can be identified. ChIP-GSM is specifically designed to infer cell type-specific CRMs by integrating multiple TFs celltype specific ChIP-seq binding signals at enhancer or gene promoter regions. Currently, there is very limited understanding of non-coding regions beyond regulatory elements, but ChIP-GSM is feasible to be extended and applied to inferring CRMs given any regions of interest.
We demonstrated that CRMs have a stronger prediction power on active regulatory elements than individual TFs. Further, using K562 cells as an example, we showed that target genes of different CRMs actively expressed at different time points and involved in distinct biological processes. This specific study revealed the functional diversity of CRMs. When TFs associated with different partners, they may regulate a different set of genes and their functional role within the cell may also change. We expected that CRMs at enhancer regions also have such function diversity. However, currently, very limited cell type-specific high-resolution 3D chromatin interaction data as ChIA-PET is available and the mapping between enhancers and genes has a lot of ambiguity, especially considering the fact that one enhancer can regulate multiple target genes and the nearest gene may not be one of them.
Currently we mainly applied ChIP-GSM to cell type-specific data as most ChIP-seq dataset were generated from cell line models. ChIP-GSM can also be applied to ChIP- 
